JAK2 as a Molecular Marker in Myeloproliferative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-6182|5|3|198-203

ISSN： 1871-5257

Source： Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol.5, Iss.3, 2007-07, pp. : 198-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fragmented ECG as a Risk Marker in Cardiovascular Diseases

By  

Current Cardiology Reviews, Vol. 10, Iss. 3, 2014-08 ,pp. : 277-286

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Endoscopy and in vivo Imaging in Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 33, Iss. 1, 2015-09 ,pp. : 32-36

Karger

Access to resources Recommend Favorite

Molecular Mechanisms of Organelle Biogenesis and Related Metabolic Diseases

By  

Medical Principles and Practice, Vol. 14, Iss. 1, 2008-07 ,pp. : 49-57

Karger

Access to resources Recommend Favorite

JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis

By Xavier Sandra   Gadelha Telma   Pimenta Glicínia   Eugenio Angela   Ribeiro Daniel   Gomes Fernanda   Bonamino Martin   Zalcberg Ilana   Spector Nelson  

Digestive Diseases and Sciences, Vol. 55, Iss. 6, 2010-06 ,pp. : 1770-1777

Springer Publishing Company

Access to resources Recommend Favorite

Angiotensin II Activates Stat5 Through Jak2 Kinase in Cardiac Myocytes

By McWhinney C.D.   Dostal D.   Baker K.  

Journal of Molecular and Cellular Cardiology, Vol. 30, Iss. 4, 1998-04 ,pp. : 751-761

Academic Press

Access to resources Recommend Favorite